Dr. Daniel Albert is an ophthalmologist at OHSU whose practice focuses on the treatment and prevention of ocular cancers and age-related macular degeneration. He specializes in conditions such as retinoblastoma, uveal melanoma, and wet macular degeneration. His clinical approach is informed by extensive research into vitamin D analogues, resveratrol, and anti-angiogenic therapies designed to inhibit tumor growth and reverse abnormal blood vessel formation in the eye.

Dr. Albert’s work also addresses neovascularization associated with age-related macular degeneration, the leading cause of vision loss in older adults. He applies his expertise in experimental eye pathology to develop innovative treatments that target ocular tumors and retinal diseases. Patients seeking care for ocular oncology or complex macular conditions may benefit from Dr. Albert’s integrated research and clinical experience.